Amosartan ranks the top in the KRW 150 billion improved drug market for 4 years
Hanmi Pharm’s Amosartan Tab 5/50mg has kept the top position in the improved drug market for 4 consecutive years.
DailyPharm analyzed actual outputs of the top 18 improved drugs for the past 4 years.
Last year, the Big 5 improved drugs were Amosartan 5/50mg(KRW 39.7 billion), Amosartan 5/100mg(...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
